Erin Doherty
Impact in
- Neurology top 5%
- Neuroblastoma Research and Treatments
-
- Cancer, Hypoxia, and Metabolism
Papers in
-
- RNA and protein synthesis mechanisms 7
- CRISPR and Genetic Engineering 6
- RNA regulation and disease 6
- RNA Research and Splicing 4
- RNA Interference and Gene Delivery 2
- Oncology 6
- CAR-T cell therapy research 4
- Co-authors
- Sibo Zhao (1 shared paper)Peter E. Zage (1 shared paper)Valeria Smith (1 shared paper)Sarah Burkhead Whittle (1 shared paper)Jennifer A. Doudna (8 shared papers)Peter A. Beal (6 shared papers)Daniel Bellieny‐Rabelo (1 shared paper)Nathan Price (2 shared papers)
- Journals
- Nature Communications (2 papers)Bone Marrow Transplantation (2 papers)Blood (2 papers)Nucleic Acids Research (2 papers)Nature (2 papers)
- Partner nations
- United StatesChinaUnited Kingdom
In The Last Decade
Erin Doherty
23 papers receiving 533 citations
Peers
Comparison fields: 5 of 60
- Neurology 227
- Cancer Research 69
- Molecular Biology 269
- Oncology 65
- Business and International Management 5
Countries citing papers authored by Erin Doherty
This map shows the geographic impact of Erin Doherty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erin Doherty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erin Doherty more than expected).
Fields of papers citing papers by Erin Doherty
This network shows the impact of papers produced by Erin Doherty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erin Doherty. The network helps show where Erin Doherty may publish in the future.
Co-authors
The 25 scholars most cited alongside Erin Doherty, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 282 | |
| 2 | 2024 | 45 | |
| 3 | 2024 | 39 | |
| 4 | 2022 | 23 | |
| 5 | 2021 | 21 | |
| 6 | 2021 | 19 | |
| 7 | 2016 | 16 | |
| 8 | 2021 | 15 | |
| 9 | 2020 | 14 | |
| 10 | 2022 | 12 | |
| 11 | 2024 | 11 | |
| 12 | 2022 | 8 | |
| 13 | 2025 | 7 | |
| 14 | 2025 | 6 | |
| 15 | 2023 | 5 | |
| 16 | 2024 | 5 | |
| 17 | 2021 | 4 | |
| 18 | 2019 | 3 | |
| 19 | 2022 | 1 | |
| 20 | 2020 | 1 |
About Erin Doherty
Erin Doherty is a scholar working on Molecular Biology, Oncology, Hematology, Genetics and Public Health, Environmental and Occupational Health, having authored 27 papers that have together received 540 indexed citations. Recurring topics across this work include RNA and protein synthesis mechanisms (7 papers), CRISPR and Genetic Engineering (6 papers), RNA regulation and disease (6 papers), Hematopoietic Stem Cell Transplantation (4 papers), CAR-T cell therapy research (4 papers), RNA Research and Splicing (4 papers), Acute Myeloid Leukemia Research (3 papers) and RNA Interference and Gene Delivery (2 papers). The work is most often cited by research in Neurology (227 citations), Cancer Research (69 citations), Molecular Biology (269 citations), Oncology (65 citations) and Business and International Management (5 citations). Erin Doherty has collaborated with scholars based in United States, China and United Kingdom. Frequent co-authors include Sibo Zhao, Peter E. Zage, Valeria Smith, Sarah Burkhead Whittle, Jennifer A. Doudna, Peter A. Beal, Daniel Bellieny‐Rabelo, Nathan Price, Jason Nomburg and Andrew J. Fisher. Their work appears in journals such as Nature Communications, Bone Marrow Transplantation, Blood, Nucleic Acids Research and Nature.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.